Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
09939 KINTOR PHARMA-B
RT Nominaldown11.600 -0.060 (-0.515%)
30/12/2021 17:17
{I-bank focus}CMB lowers Kintor Pharma (09939) to HK$35.22
[ET Net News Agency, 30 December 2021] CMB International lowered its target price for Kintor Pharma (09939) to HK$35.22 from HK$98.07 and maintain ... View All View All

03/01/2022 10:40
Kintor Pharma (09939) doses first patient in phase III trial
[ET Net News Agency, 3 January 2022] Kintor Pharmaceutical Limited (09939) said the company has on 31 December 2021 enrolled and dosed the first p ... View All View All

Remark: Real time quote last updated: 17/01/2022 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2022 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.